Omeros Corporation (NASDAQ: OMER) Q1 2025 Earnings Call Transcript May 15, 2025 Omeros Corporation misses on earnings ...

Operator: Greetings and welcome to the BiomX First Quarter 2025 Financial Results Conference Call. At this time, all ...

But with the surge in popularity of ‘natural’ ingredients in toothpaste, many are including them in their oral care routines ...

Jessica Simpson will continue to cement her return to music by headlining the annual 'Women Who Rock' Benefit Concert ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

Earlier this afternoon, Gossamer Bio issued a press release announcing its first-quarter 2025 financial results and provided a corporate update. Please note that certain information discussed on the ...

RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and Liberty Star Minerals (OTCQB:LBSR) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this ...

BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced today that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — ...

Wellbeing Nutrition has since expanded into 20 formats, including oral thin strips, which the company says now lead globally ...

On May 15, 2025 , the latest announcement released by the National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market.